Back
Cardiol Therapeutics Stock Price Chart
10 stocks to buy for the next leg of this rally
Get the full list here FREE
Buy
62
CRDL
Cardiol Therapeutics
Last Price:
$1.25
Seasonality Move:
6.21%
7 Day Trial
ALL ACCESS PASS
$
7
10 Best Stocks to Own in 2025
Get your copy now FREE!-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRDL is experiencing slight buying pressure.
Cardiol Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.16 | Buy |
| 20-day SMA: | 1.14 | Buy |
| 50-day SMA: | 1.06 | Buy |
| 200-day SMA: | 1.48 | Sell |
| 8-day EMA: | 1.19 | Buy |
| 20-day EMA: | 1.14 | Buy |
| 50-day EMA: | 1.12 | Buy |
| 200-day EMA: | 1.35 | Sell |
Cardiol Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 63.31 | Buy |
| Chaikin Money Flow: | 38661 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.07 - 1.19) | Buy |
| Bollinger Bands (100): | (1.01 - 1.29) | Buy |
Cardiol Therapeutics Technical Analysis
| May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Cardiol Therapeutics Stock
Is Cardiol Therapeutics Stock a Buy?
-
Cardiol Therapeutics share price is 1.25 while CRDL 8-day simple moving average is 1.16, which is a Buy signal.
-
The stock price of CRDL is 1.25 while Cardiol Therapeutics 20-day SMA is 1.14, which makes it a Buy.
-
Cardiol Therapeutics 50-day simple moving average is 1.06 while CRDL share price is 1.25, making it a Buy technically.
-
CRDL stock price is 1.25 and Cardiol Therapeutics 200-day simple moving average is 1.48, creating a Sell signal.
CRDL Technical Analysis vs Fundamental Analysis
Buy
62
Cardiol Therapeutics (CRDL)
is a Buy
Is Cardiol Therapeutics a Buy or a Sell?
-
Cardiol Therapeutics stock is rated a BuyThe current Cardiol Therapeutics [CRDL] share price is $1.25. The Score for CRDL is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
Cardiol Therapeutics Stock Info
Market Cap:
103.3M
Price in USD:
1.25
Share Volume:
116K
Cardiol Therapeutics 52-Week Range
52-Week High:
3.12
52-Week Low:
0.77
Buy
62
Cardiol Therapeutics (CRDL)
is a Buy
Cardiol Therapeutics Share Price Forecast
-
What is the Cardiol Therapeutics stock price today?The Cardiol Therapeutics stock price is 1.25 USD today.
-
Will CRDL stock go up or go down?Cardiol Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Cardiol Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cardiol Therapeutics is not overvalued.
Is Cardiol Therapeutics Stock a Buy?
-
Cardiol Therapeutics share price is 1.25 while CRDL 8-day exponential moving average is 1.19, which is a Buy signal.
-
The stock price of CRDL is 1.25 while Cardiol Therapeutics 20-day EMA is 1.14, which makes it a Buy.
-
Cardiol Therapeutics 50-day exponential moving average is 1.12 while CRDL share price is 1.25, making it a Buy technically.
-
CRDL stock price is 1.25 and Cardiol Therapeutics 200-day simple moving average is 1.35, creating a Sell signal.
Fundamental Analysis of Cardiol Therapeutics
Is Cardiol Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.03 per share.
Technical Analysis of Cardiol Therapeutics
Should I short Cardiol Therapeutics stock?
-
CRDL Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting Cardiol Therapeutics is a Buy
-
Cardiol Therapeutics Relative Strength Index (RSI) is 63.31, which suggest Cardiol Therapeutics is overbought
-
The Bollinger Bands (25) for Cardiol Therapeutics is (1.07 - 1.19), which suggest Cardiol Therapeutics is a Buy
-
The Bollinger Bands (100) for Cardiol Therapeutics is (1.01 - 1.29), which suggest Cardiol Therapeutics is a Buy
* Cardiol Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.